Literature DB >> 825022

Synergism of cefazolin-gentamicin against enterococci.

M Bourque, R Quintiliani, R C Tilton.   

Abstract

A miniaturized technique for detecting antibiotic synergy by using microliter volumes was perfected. With this microtiter serial dilution method, the effect of the previously untried combination of cefazolin and gentamicin on 10 strains of enterococci was evaluated. At clinically achievable concentrations, the combination of cefazolin and gentamicin was found to be synergistic against all 10 strains when the data were plotted in the form of an isobologram. These results were compared with the conventional method of detecting synergy in vitro, namely, the determination of the rate of killing of the microorganisms with the antibiotics, singly and in combination. Similar results were also observed. These findings indicate that the microtiter serial dilution technique is a useful method for the routine determination of drug synergy. Moreover, in a patient with penicillin hypersensitivity and enterococcal infection, the combination of cefazolin and gentamicin should be considered for possible therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825022      PMCID: PMC429706          DOI: 10.1128/AAC.10.1.157

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  PENICILLIN HYPERSENSITIVITY IN PATIENTS WITH BACTERIAL ENDOCARDITIS.

Authors:  M H GRIECO; M R DUBIN; J L ROBINSON; M J SCHWARTZ
Journal:  Ann Intern Med       Date:  1964-02       Impact factor: 25.391

2.  Semiautomatic microtechnique for serial dilution-antibiotic sensitivity testing in the clinical laboratory.

Authors:  J D MacLowry; H H Marsh
Journal:  J Lab Clin Med       Date:  1968-10

3.  Penicillin and gentamicin therapy for enterococcal infections.

Authors:  A J Weinstein; R C Moellering
Journal:  JAMA       Date:  1973-02-26       Impact factor: 56.272

4.  Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patients.

Authors:  C K Friedberg; K M Rosen; P A Bienstock
Journal:  Arch Intern Med       Date:  1968-08

5.  Antimicrobial susceptibility of group D hemolytic streptococci (enterococci).

Authors:  H J Simon
Journal:  Am J Med Sci       Date:  1967-01       Impact factor: 2.378

6.  Penicillin combined with gentamicin or streptomycin: synergism against enterococci.

Authors:  C Watanakunakorn
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Comparative synergistic activity of nafcillin, oxacillin, and methicillin in combination with gentamicin against.

Authors:  R H Glew; R S Millering; C Wennersten
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

8.  Microdilution antibiotic susceptibility test: examination of certain variables.

Authors:  R C Tilton; L Lieberman; E H Gerlach
Journal:  Appl Microbiol       Date:  1973-11

Review 9.  Treatment of infective endocarditis--1973.

Authors:  L Weinstein; J Schlesinger
Journal:  Prog Cardiovasc Dis       Date:  1973 Nov-Dec       Impact factor: 8.194

10.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

View more
  8 in total

1.  Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.

Authors:  R S Griffith; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Outbreak of multiply drug-resistant Proteus mirabilis originating in a surgical intensive care unit: in vitro susceptibility pattern.

Authors:  T T Yoshikawa; S A Shibata; A W Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

3.  Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Authors:  James J Howard; Carolyn R Sturge; Dina A Moustafa; Seth M Daly; Kimberly R Marshall-Batty; Christina F Felder; Danniel Zamora; Marium Yabe-Gill; Maria Labandeira-Rey; Stacey M Bailey; Michael Wong; Joanna B Goldberg; Bruce L Geller; David E Greenberg
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.

Authors:  N K Ayisi; V S Gupta; J B Meldrum; A K Taneja; L A Babiuk
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  In vitro antibacterial activity of amikacin and ticarcillin, alone and in combination, against Pseudomonas aerurginosa.

Authors:  T T Yoshikawa; S A Shibata
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

6.  Methodological variation in antibiotic synergy tests against enterococci.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

7.  Enterococcal bacteremia: clinical implications and determinants of death.

Authors:  R N Garrison; D E Fry; S Berberich; H C Polk
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

8.  Local Injection of Aminoglycosides for Prophylaxis Against Infection in Open Fractures.

Authors:  Cheryl Reese Lawing; Feng-Chang Lin; Laurence E Dahners
Journal:  J Bone Joint Surg Am       Date:  2015-11-18       Impact factor: 5.284

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.